Pseudolaric Acid B

CAT:
804-HY-N6939-01
Size:
5 mg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Pseudolaric Acid B - image 1

Pseudolaric Acid B

  • UNSPSC Description:

    Pseudolaric Acid B is a diterpene isolated from the root of Pseudolarix kaempferi (pinaceae), has anti-cancer, antifungal, and antifertile activities, and shows immunosuppressive activity on T lymphocytes[1][2][3]. Pseudolaric Acid B inhibits hepatitis B virus (HBV) secretion through apoptosis and cell cycle arrest. Pseudolaric Acid B induces autophagy[4][5].
  • Target Antigen:

    Apoptosis; Autophagy; Ferroptosis; Fungal; HBV
  • Type:

    Natural Products
  • Related Pathways:

    Anti-infection;Apoptosis;Autophagy
  • Applications:

    Neuroscience-Neurodegeneration
  • Field of Research:

    Cancer; Infection; Inflammation/Immunology
  • Assay Protocol:

    https://www.medchemexpress.com/pseudolaric-acid-b.html
  • Purity:

    99.47
  • Solubility:

    DMSO : 50 mg/mL (ultrasonic)
  • Smiles:

    O=C(C1=CC[C@@]([C@@](CC1)(OC(C)=O)[C@]2([H])[C@@](C)(/C=C/C=C(C(O)=O)\C)O3)(CC2)C3=O)OC
  • Molecular Weight:

    432.46
  • References & Citations:

    [1]Zhou BN, et al. Some progress on the chemistry of natural bioactive terpenoids from Chinese medicinal plants. Mem Inst Oswaldo Cruz. 1991;86 Suppl 2:219-26.|[2]Wang WC, et al. [Endocrine activity of pseudolaric acids A and B and their effects on sex hormones, prostaglandins, uteri, and fetuses]. Zhongguo Yao Li Xue Bao. 1991 Mar;12(2):187-90.|[3]Wei N, et al. The immunosuppressive activity of pseudolaric acid B on T lymphocytes in vitro. Phytother Res. 2013 Jul;27(7):980-5.|[4]Yu J, et al. Pseudolaric acid B inhibits the secretion of hepatitis B virus. Oncol Rep. 2017 Jan;37(1):519-525.|[5]Yu J, et al. Pseudolaric acid B activates autophagy in MCF-7 human breast cancer cells to prevent cell death. Oncol Lett. 2016 Mar;11(3):1731-1737.
  • Shipping Conditions:

    Room Temperature
  • Storage Conditions:

    4°C (Powder, protect from light)
  • Clinical Information:

    No Development Reported
  • CAS Number:

    82508-31-4